Introduction {#sec1}
============

Membrane proteins are a central subclass of the proteome ([@bib21]). They are involved in many essential biological processes, including cell signaling, cell adhesion, transport across the lipid bilayer, transduction of energy, and immune response. As such, membrane proteins are implicated in many disorders and are key targets for diagnostics and therapeutics. Prerequisite to conducting any research into membrane protein function is the successful production of the protein of interest in a functional form. Producing intact membrane proteins is an inherently challenging task due to their requirement for a lipid environment, and while remarkable achievements have been made in the past several years toward the production of membrane proteins, the requirement for lipidic environment remains a severe restriction to the structure determination of these otherwise desirable targets ([@bib12]). Most procedures developed involve isolating the protein by detergent solubilization, followed by a purification step and subsequent reconstitution into an artificial membrane e.g., liposomes, bicelles, or nanodiscs ([@bib3; @bib23]). These procedures are highly time consuming and suffer from further drawbacks, including low yields and high cost. Perhaps most importantly, preserving the correct topology of membrane proteins is often crucial for their function but is very difficult to achieve during reconstitution experiments. Additionally, the biological relevance of in vitro model systems is limited by the relative simplicity of the lipid composition of the artificial membranes when compared to native membranes that comprise a considerably more diverse range of lipids, often with specific ratios that can also form local subdomains ([@bib19]).

Membrane enveloped viruses have been successfully used as a platform for displaying intact membrane proteins on their surface. This approach is referred to as pseudotyping, a process in which the native virus surface protein is replaced with the protein of interest. This gives rise to membrane proteins that are properly folded and oriented on cell-derived membranes. Vesicular stomatitis virus (VSV) is a favorable platform for the pseudotyping approach with well-demonstrated success ([@bib24]). Simpler systems that circumvent the related biosafety laboratory requirements for work with VSV pseudotypes are virus-like particles (VLPs) that have been likewise applied successfully to display membrane proteins ([@bib14]). However, an inherent limitation of the virus-based and VLP approaches is the need for viral components. Additionally, integral membrane proteins with bulky cytoplasmic domains will not be readily packed into either pseudotyped viruses or VLPs due to steric hindrances from the virus capsid or matrix proteins. Furthermore, in these cases the cytoplasmic domain of the membrane protein is potentially altered.

With the aforementioned limitations in mind, we have developed an alternative approach that provides high yields of cell-derived, membrane protein-enriched extracellular vesicles (MPEEVs). The basis for this approach is the utilization of the recently characterized biological process of membrane vesicle secretion ([@bib5]). Extracellular vesicle secretion seems to be a universal and evolutionary conserved process under both physiological and pathological conditions. Chemical vesiculants like paraformaldehyde in combination with dithiothreitol can induce release of giant plasma membrane vesicles. However, these agents have severe effects on the integrity of the proteins and thus often limit the use of such preparations to study membrane biophysics ([@bib18]). The here presented approach does not require any vesiculants or viral components.

Results and Discussion {#sec2}
======================

MPEEV Production and Characterization {#sec2.1}
-------------------------------------

To produce extracellular vesicles enriched with a specific membrane protein, adherent mammalian cells were transfected with the gene corresponding to the full-length protein of interest in a standard expression vector using an actin promoter. The overexpression of the protein resulted in the accumulation of MPEEVs in the growth medium (for details, see the [Experimental Procedures](#sec3){ref-type="sec"}). The source compartment of the vesicles might vary from protein to protein. The MPEEVs were then separated from producer cells by differential centrifugation of the supernatant.

We have applied this method to three integral membrane proteins, namely the *Caenorhabditis elegans* cell-cell fusion proteins AFF-1 and EFF-1 and the glycoprotein B (gB) from Herpes simplex virus type 1 (HSV1). To estimate the relative enrichment of the corresponding membrane protein in the MPEEVs, an aliquot of the vesicle preparation was loaded on SDS-PAGE ([Figure 1](#fig1){ref-type="fig"}). While some contaminants were observed, a major band at the expected molecular weight was clearly apparent for each of the three different samples. Based on the SDS-PAGE, the estimated yield from one T175 flask was 50--100 μg of protein. To further quantify the relative enrichment and analyze the nature of the contaminants, the MPEEVs were analyzed by mass spectrometry using an exponentially modified protein abundance index (emPAI) ([Table 1](#tbl1){ref-type="table"}). The emPAI analysis verified that the corresponding membrane protein of interest is the most abundant protein in the respective vesicle preparation, correlating well with the SDS-PAGE results. Importantly, no other membrane proteins were detected and most of the other proteins found were contaminants, either from the serum added to the cell culture medium or from the transfection reagent.

To characterize the protein incorporation in the membrane, the vesicles were imaged with electron cryomicroscopy (cryo-EM) and electron cryotomography (cryo-ET). The size and morphology of the vesicles were dependent on the displayed protein ([Figure 2](#fig2){ref-type="fig"}). For HSV1 gB and AFF-1, the vesicles were mostly spherical and ∼100 nm in diameter. EFF-1 vesicles were generally smaller in diameter and had variable morphologies. In the case of HSV1 gB, we observed elongated spikes protruding from the membrane (∼16 nm; [Figure 2](#fig2){ref-type="fig"}A). In the case of AFF-1 and EFF-1, the vesicle membranes were uniformly covered with an ∼12--14 nm thick protein layer that appeared to consist of discrete densities protruding radially outward from the membrane ([Figures 2](#fig2){ref-type="fig"}B and 2C). In control vesicle preparations, where the cells were transfected with an expression plasmid for cytosolic yellow fluorescence protein (YFP), notably ∼100× less vesicles were secreted. These vesicles could be seen to display only very small, extra-membranous densities, which were clearly different from those observed for the MPEEVs ([Figure 2](#fig2){ref-type="fig"}D versus [Figures 2](#fig2){ref-type="fig"}A--2C). This indicates that our experimental system is highly suitable for specifically displaying topologically correct membrane proteins, and vesicle secretion is induced by the expression of the membrane proteins. Furthermore, to demonstrate the stability of these preparations, we have successfully imaged vesicles after storage in buffer at 4°C for over 2 months without noticing any decay. This characteristic might be crucial for a number of nonstructural applications.

Structure Determination from MPEEVs {#sec2.2}
-----------------------------------

To generate a 3D reconstruction of the membrane proteins in the context of the membrane we have applied cryo-ET with subsequent averaging of tomographic subvolumes. Subvolume averaging is a method of aligning and averaging a large number of extracted volumes that contain the structure of interest, in order to greatly improve the signal-to-noise ratio ([@bib2; @bib4]). For the EFF-1 and gB structures ([Figure 3](#fig3){ref-type="fig"}), several hundred subvolumes were automatically picked at the vesicle surfaces using a local minimum search. These volumes were then iteratively aligned and averaged in an unbiased, reference-free manner. The resulting 3D reconstruction of the elongated spikes observed for gB showed a 3-fold symmetry and was very similar to the postfusion crystal structure of gB ([@bib6]) and the 3D reconstruction of the ectodomain bound to liposomes ([@bib11]) ([Figure 3](#fig3){ref-type="fig"}C). The resulting 3D reconstruction of natively-anchored EFF-1 had an asymmetric elongated shape ([Figure 3](#fig3){ref-type="fig"}D). For further details on the EFF-1 3D reconstruction, see [@bib26]. In that study, it was shown that vesicles could have substantially different morphologies, depending on the protein displayed and the time point of harvest. Furthermore, imaging of vesicles undergoing fusion revealed highly elusive membrane rearrangements occurring during AFF-1- and EFF-1-mediated fusion ([@bib26]).

Subvolume averaging, in addition to the 3D structure, provides the means to analyze the membrane proteins spatial distribution and to probe whether higher order assemblies are apparent. This analysis was performed by subsequently back-plotting the average structure into orientations and positions at which the proteins were found on the membrane thus enabling to visualize and assess the relative protein topology and interprotein interactions ([Figures 3](#fig3){ref-type="fig"}E and 3F; [Movies S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"} available online). For the examples presented, no ordered lattice or preferred intermolecular interaction was observed in the case of EFF-1. In the case of HSV1 gB some patches of trimers showed preferred lateral interaction presumably mediated by the trimer midregions as observed earlier for the soluble gB ectodomain upon interaction with artificial liposomes ([@bib11]).

In summary, the experimental system described here works independent of detergents, vesiculants, and viruses, and as such, we envisage MPEEVs being used in a broad number of applications. As the vesicles originate from cells, the intact membrane protein is embedded in membranes with a native lipid composition. MPEEVs can be potentially isolated from a wide variety of cell-wall free cell types. The success in MPEEV production relies on the overexpression of the protein of interest and as a high level of expression is crucial, plasmids using a strong promoter are required. The optimum time, posttransfection, for collecting the MPEEVs will vary for different proteins and needs to be determined case by case. However, this optimization is very fast and high quality material can be produced within a week as opposed to several months or even years required for solubilization and reconstitution-based approaches. Here, results are presented for three type I transmembrane proteins, the extent to which this method is applicable for studying other families of membrane proteins remains to be determined. As demonstrated here, the coupling of this experimental system with techniques that are ideally suited to study proteins within biological membranes such as cryo-EM and cryo-ET enabled structural characterization of the membrane protein of interest. Additionally, MPEEVs can be used as highly protein-enriched, semipurified starting material for classical detergent-based purification approaches currently applied for structure determination by crystallography or NMR. The applications for MPEEVs, however, are not limited to structural determination. They can credibly be used for a wide range of exciting applications including antibody generation, protein-protein interaction assays, diagnostics use, biomarkers, and possibly therapeutics.

Experimental Procedures {#sec3}
=======================

Vesicle Preparation {#sec3.1}
-------------------

Adherent Baby Hamster Kidney cells (BHK-21, clone 13, ECACC 85011433) were grown in a T175 flask; at ∼70% confluency, they were transfected with either *aff-1* ([@bib1]), *eff-1A* ([@bib1]), or HSV1 gB ([@bib15]) gene in pCAGGS plasmid using Lipofectamine (Invitrogen). Following a 2 hr incubation at 37°C and 5% CO~2~, the medium with the transfection reagent was removed and replaced by 2% FBS/GMEM-CM (Invitrogen). Transfected cells were allowed to grow for 24 hr or 48 hr at 37°C and 5% CO~2~. Following the incubation, the medium was collected and cleared from cell debris by centrifugation at 3,000 × *g* for 20 min and 4°C. The vesicles were pelleted through a 20% sucrose cushion at 100,000 × *g*, and resuspended in 25 mM HEPES pH 7.4, 130 mM NaCl. For AFF-1 and EFF-1 vesicle preparations each 19 independent repeats were performed for gB 11 independent repeats were performed. For every vesicle preparation, 2 aliquots were analyzed by cryo-EM.

Mass Spectrometry Analysis {#sec3.2}
--------------------------

For the analysis of protein composition, vesicles were precipitated using chloroform/methanol as described previously ([@bib22]) followed by in-solution trypsin digestion ([@bib25]). The mass spectrometry analysis was performed by nano ultraperformance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) using a nano Acquity UPLC system coupled to a QTOF premier (Waters) as described previously ([@bib9]). MS/MS spectra were searched against the National Center for Biotechnology Information (NCBI) database and proteins identified quantified in a relative fashion using the empirically modified abundance index (emPAI) approach as described ([@bib7; @bib20]) ([Table 1](#tbl1){ref-type="table"}). For each vesicle type (gB, EFF-1, AFF-1), mass spectrometry analysis was performed from two independent preparations and found to be highly similar. The data given in [Table 1](#tbl1){ref-type="table"} is the result from one of these experiments.

Electron Cryo Microscopy Data Collection {#sec3.3}
----------------------------------------

Microscopy was performed at either 200 keV or 300 keV using a TF30 "Polara" electron microscope (FEI) equipped with a QUANTUM 964 postcolumn energy filter (Gatan) operated in zero-loss imaging mode. A 50 μm C2 aperture and a 20 eV energy-selecting slit were used. Projection images and tilt series were recorded on a 4 k × 4 k CCD camera or K2 summit direct detector at a nominal magnification of 95,000× or 77,000× resulting in a calibrated pixel size of 0.38 nm or 0.28 nm at the specimen. Tilt series were collected at 200 kV or 300 kV using SerialEM ([@bib10]) at a defocus of --2 μm in 3° or 4° increments covering an angular range from --60° to 60°. The total electron dose for the tilt series was kept between 60 and 80 electrons/Å^2^.

Tomographic Reconstructions {#sec3.4}
---------------------------

Tomographic reconstructions were calculated in IMOD ([@bib8]) using weighted back-projection ([@bib17]).

Subvolume Picking {#sec3.5}
-----------------

Subvolumes were picked using a local minima search on 4× binned and Gaussian-filtered versions of the tomograms as described ([@bib26]). In brief, all local minima with intensities lower than 2 SD below the mean, and within ∼150 Å of the manually segmented vesicle membrane, were considered as particles to be averaged, resulting in 1,973 subvolumes for EFF-1 and 1,380 subvolumes for gB. Initial orientations of the sub-volume "boxes" were approximated as normal to the membrane. Using PEET version 1.9 ([@bib13]), five iterations of alignment against the initial average of all 1,973 subvolumes were performed on unmasked particles, in order to refine the picking while aligning the membrane as well as the particle. For EFF-1, the 801 subvolumes giving cross-correlation scores above the mean were subsequently used for subvolume averaging. For gB, 748 subvolumes from the two tomograms giving the most consistent averages were used. Using UCSF Chimera ([@bib16]), the orientations and positions of these subvolumes were visualized concurrently with the filtered tomogram maps to validate the results of the picking process.

Subvolume Averaging {#sec3.6}
-------------------

Averaging was performed using PEET version 1.9 ([@bib13]). The picked subvolumes for each protein were split into two evenly sized groups (based on even and odd particle indices) for the averaging and the final FSC calculation. For each of these four groups (two for EFF-1, two for gB) the average of all particles in the group was used as the initial template. Six iterations of refinement of the positions and orientations with successively finer sampling increments while including progressively higher spatial frequency information were applied, with the particles masked to remove the membrane and neighboring particles. The resulting structures from the two independent refinements were aligned and the resolution determined using Fourier shell correlation (FSC). The gB reconstruction went through four more iterations of refinement with 3-fold symmetry applied.

The final structure, created by refining and averaging all 801 subvolumes for EFF-1 and all 748 subvolumes for gB, was low-pass filtered using a Gaussian curve with a width matching the FSC curve. The membrane structure from the initial picking and the final particle structure were then plotted back into their relative positions on the original tomogram.

UCSF Chimera ([@bib16]) was used for visualization, rigid body fitting of the crystal structure, and preparation of the figures.
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![Analysis of MPEEVs by SDS-PAGE\
(A) Vesicle preparation with Herpes simplex virus 1 (HSV1) glycoprotein B (gB). gB appears as prominent band at a molecular weight of ∼110 kDa.\
(B) Vesicle preparation with the *C. elegans* fusion proteins EFF-1 and AFF-1, the proteins appear as predominant bands at a molecular weight of ∼97 kDa.](gr1){#fig1}

![Visualization by of MPEEVs by Cryo-EM\
Projection images of vesicles collected from the culture medium of cells transfected with the expression plasmid for full-length HSV1 gB (A; defocus −3 μm); full-length AFF-1 (B; defocus −5 μm); full-length EFF-1 (C; defocus −5 μm) and cytosolic YFP (D; defocus −5 μm). Scale bar represents 100 nm.](gr2){#fig2}

![3D EM Reconstruction of the Proteins on the Membrane\
(A and B) Central and tangential slices through a tomogram of MPEEVs displaying gB (A) and EFF-1 (B). Scale bar represents 50 nm.\
(C and D) Isosurface representation of the sub-volume reconstruction of gB with the trimer crystal structure (Protein Data Bank \[PDB\]: [2GUM](pdb:2GUM){#intref0015}) fitted (C) and EFF-1 EM map with a protomer of EFF-1 crystal structure (PDB: [4OJC](pdb:4OJC){#intref0020}) flexibly fitted (D), side (left) and top views (right) are presented. Membrane is shown in light blue; protein in orange. Scale bar represents 5 nm.\
(E and F) Isosurface representations of the tomograms shown in (A and B). The subvolume reconstruction and the membrane were placed back into the determined position and orientation of individual protein spikes such enabling analysis of relative orientations and interactions. Scale bar represents 50 nm.\
See also [Movies S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc2){ref-type="supplementary-material"}.](gr3){#fig3}

###### 

Major Proteins Identified by Mass Spectrometry in the Vesicles Preparations and Their Relative Abundance

  Protein Name[a](#tblfn1){ref-type="table-fn"}               NCBI Accession                                 Mass (Da)   HSV1 gB   AFF-1   EFF-1                                   
  ----------------------------------------------------------- ---------------------------------------------- ----------- --------- ------- ------- ----- ------ ---- ------ ------ ----
  Envelope glycoprotein B (HSV1)                              [1353200](ncbi-geo:1353200){#intref0025}       100,875     16,873    70.91   27.6                                    
  Protein AFF-1 anchor cell fusion failure-1 (*C. elegans*)   [193204255](ncbi-geo:193204255){#intref0030}   68,617                                974   2.07   33                 
  Protein EFF-1, isoform a (*C. elegans*)                     [71982882](ncbi-geo:71982882){#intref0035}     75,494                                                  1004   1.66   16
  Histone H2B homolog                                         [156371481](ncbi-geo:156371481){#intref0040}   24,545                                225   1.78   28   392    1.78   17
  Actin family[e](#tblfn5){ref-type="table-fn"}               [178045](ncbi-geo:178045){#intref0045}         26,147      2,918     46.51   18.1    221   1.05   17   185    0.35   3
  Hemoglobin fetal subunit beta                               [62460494](ncbi-geo:62460494){#intref0050}     15,963      998       33.03   12.9    95    0.78   12   234    1.62   15
  Pyruvate kinase PKM                                         [146345448](ncbi-geo:146345448){#intref0055}   58,378      2,081     18.19   7.0                                     
  Tubulin beta-3 chain                                        [12963615](ncbi-geo:12963615){#intref0060}     50,842      1,422     17.00   6.6                       134    0.37   3
  14-3-3 protein zeta                                         [82197807](ncbi-geo:82197807){#intref0065}     27,929      625       16.42   6.4                                     
  Ras-related protein Rap                                     [75077355](ncbi-geo:75077355){#intref0070}     21,040      356       13.03   5.1                                     
  Annexin A2                                                  [113951](ncbi-geo:113951){#intref0075}         38,937      1,730     12.89   5.0                                     
  T-complex protein 1 subunit zeta                            [115305833](ncbi-geo:115305833){#intref0080}   58,376      405       10.15   4.0                                     
  Class-III intermediate filaments                            [138535](ncbi-geo:138535){#intref0085}         53,754      1,500     9.64    3.8                                     
  Tubulin alpha                                               [116256086](ncbi-geo:116256086){#intref0090}   50,804      1,614     9.10    3.5                                     
  Histone cluster 1, H2ag-like                                [291410763](ncbi-geo:291410763){#intref0095}   27,347                                                  141    1.00   10
  Serum albumin                                               [1351907](ncbi-geo:1351907){#intref0100}       71,244                                152   0.20   3    282    0.31   3
  Galectin-3-binding protein                                  [81861611](ncbi-geo:81861611){#intref0105}     65,270                                272   0.41   7    315    0.63   6
  60S acidic ribosomal protein P2                             [133062](ncbi-geo:133062){#intref0110}         4,692                                                   72     0.79   8
  40S ribosomal protein SA-like                               [296190805](ncbi-geo:296190805){#intref0115}   32,906                                                  182    0.47   4
  Guanine nucleotide-binding protein subunit beta-2-like 1    [5174447](ncbi-geo:5174447){#intref0120}       35,511                                                  170    0.56   5
  Glyceraldehyde-3-phosphate dehydrogenase-like               [488563203](ncbi-geo:488563203){#intref0125}   35,942                                                  190    0.55   5
  Laminin-binding protein                                     [34234](ncbi-geo:34234){#intref0130}           31,888                                                  197    0.49   5

All proteins other than gB of HSV1 and AFF-1 and EFF-1 of *C. elegans* are originating either from the BHK cells used to produce the vesicles or contaminations, either from the serum added to the cell culture or transfection reagent.

Mascot score for confidence of protein identification is defined as the --log value of the probability P that this assignment is made by chance ([@bib9]).

Exponentially modified protein abundance index (emPAI) analysis ([@bib7; @bib20]).

Relative abundance (Rel. Abund.) in respect to the proteins with the highest emPAI listed in this table.

Actin family representing gamma-actin, cytoplasmic actin 2, actin-cytoplasmic 1-like.
